Contracts › 75N93022C00054
75N93022C00054: Adjuvant Comparison and Characterization
Awarded to University of California Irvine by National Institutes of Health (NIH).
$13.0Mobligated
$13.0Mpotential value
30 April 2028current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N93022C00054 |
|---|---|
| Awardee | University of California Irvine |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541714 Research and Development in Biotechnology (Except Nanobiotechnology) |
| PSC | AN11 Health R&D Services; Health Care Services; Basic Research |
| Place of performance | CA |
| Offers received | 10 |
| Period of performance | 01 September 2022 to 30 April 2028 |
| Potential end | 30 April 2028 |
| Estimated recompete solicitation | ~Q4 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541714 contracts · All expiring contracts · USASpending record